From: Nonadditivity in public and inhouse data: implications for drug design
Observations
Mean
Variance
Std
Skewness
Kurtosis
AstraZeneca
3,053,055
0
0.42
0.65
3.13
ChEMBL
1,246,975
0.46
0.68
0.01
4.52